JANUS HENDERSON GROUP PLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$6,002,639
-3.7%
388,018
-2.2%
0.00%0.0%
Q2 2023$6,233,267
-8.2%
396,771
-3.7%
0.00%0.0%
Q1 2023$6,786,753
+1.7%
411,818
-3.7%
0.00%
-20.0%
Q4 2022$6,671,496
+16.2%
427,660
-51.6%
0.01%
+25.0%
Q3 2022$5,739,734
-10.6%
884,252
+93.5%
0.00%0.0%
Q2 2022$6,417,000
-4.2%
457,075
-2.3%
0.00%
+33.3%
Q1 2022$6,698,000
+19.9%
467,760
+14.1%
0.00%
+50.0%
Q4 2021$5,586,000
-26.7%
409,810
-11.9%
0.00%
-33.3%
Q3 2021$7,624,000
-21.4%
465,420
-19.3%
0.00%
-25.0%
Q2 2021$9,705,000
-18.4%
576,634
-11.5%
0.00%
-20.0%
Q1 2021$11,898,000
+12.3%
651,594
+11.9%
0.01%0.0%
Q4 2020$10,599,000
-15.3%
582,351
-16.9%
0.01%
-28.6%
Q3 2020$12,509,000
-7.7%
701,149
-7.2%
0.01%
-12.5%
Q2 2020$13,550,000
+21.4%
755,737
+2.7%
0.01%0.0%
Q1 2020$11,166,000
-53.3%
735,599
-39.2%
0.01%
-33.3%
Q4 2019$23,886,000
-2.6%
1,210,656
-15.1%
0.01%
-7.7%
Q3 2019$24,536,000
-6.4%
1,426,481
-3.6%
0.01%
-7.1%
Q2 2019$26,205,000
-12.1%
1,480,487
+1.2%
0.01%
-17.6%
Q1 2019$29,809,000
+159.7%
1,463,400
+114.5%
0.02%
+142.9%
Q4 2018$11,477,000682,3320.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders